Find Research Outputs

Search concepts
Selected Filters
2018
1 Citations

Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect

Rashidi, A., Ebadi, M., Said, B., Cao, Q., Shanley, R., Curtsinger, J., Bejanyan, N., Warlick, E. D., Green, J. S., Brunstein, C. G., Miller, J. S. & Weisdorf, D. J., Aug 1 2018, In : American Journal of Hematology. 93, 8, p. 1014-1019 6 p.

Research output: Contribution to journalArticle

Fetal Blood
Allografts
Viruses
Transplants
Neoplasms
3 Citations

Adaptive NK cells resist regulatory T-cell suppression driven by IL37

Sarhan, D., Hippen, K. L., Lemire, A., Hying, S., Luo, X., Lenvik, T., Curtsinger, J., Davis, Z., Zhang, B., Cooley, S. A., Cichocki, F. M., Blazar, B. R. & Miller, J. S., Jul 1 2018, In : Cancer immunology research. 6, 7, p. 766-775 10 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Natural Killer Cells
Natural Killer Cell Receptors
Tumor Microenvironment
Programmed Cell Death 1 Receptor
3 Citations

A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors

Miller, J. S., Morishima, C., McNeel, D. G., Patel, M. R., Kohrt, H. E. K., Thompson, J. A., Sondel, P. M., Wakelee, H. A., Disis, M. L., Kaiser, J. C., Cheever, M. A., Streicher, H., Creekmore, S. P., Waldmann, T. A. & Conlon, K. C., Apr 1 2018, In : Clinical Cancer Research. 24, 7, p. 1525-1535 11 p.

Research output: Contribution to journalArticle

Interleukin-15
Outpatients
Neoplasms
T-Lymphocytes
Troponin
7 Citations

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

Wrangle, J. M., Velcheti, V., Patel, M. R., Garrett-Mayer, E., Hill, E. G., Ravenel, J. G., Miller, J. S., Farhad, M., Anderton, K., Lindsey, K., Taffaro-Neskey, M., Sherman, C., Suriano, S., Swiderska-Syn, M., Sion, A., Harris, J., Edwards, A. R., Rytlewski, J. A., Sanders, C. M., Yusko, E. C. & 9 othersRobinson, M. D., Krieg, C., Redmond, W. L., Egan, J. O., Rhode, P. R., Jeng, E. K., Rock, A. D., Wong, H. C. & Rubinstein, M. P., May 1 2018, In : The Lancet Oncology. 19, 5, p. 694-704 11 p.

Research output: Contribution to journalArticle

Interleukin-15
Non-Small Cell Lung Carcinoma
Immunotherapy
ALT-803
nivolumab
3 Citations

ALT-803 transiently reduces simian immunodeficiency virus replication in the absence of antiretroviral treatment

Ellis-Connell, A. L., Balgeman, A. J., Zarbock, K. R., Barry, G., Weiler, A., Egan, J. O., Jeng, E. K., Friedrich, T., Miller, J. S., Haase, A. T., Schacker, T. W., Wong, H. C., Rakasz, E. & O'Connor, S. L., Feb 1 2018, In : Journal of Virology. 92, 3, e01748-17.

Research output: Contribution to journalArticle

Simian immunodeficiency virus
Simian Immunodeficiency Virus
Virus Replication
virus replication
T-lymphocytes
1 Citations

A Phase 1 Trial of CNDO-109–Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia

Fehniger, T. A., Miller, J. S., Stuart, R. K., Cooley, S., Salhotra, A., Curtsinger, J., Westervelt, P., DiPersio, J. F., Hillman, T. M., Silver, N., Szarek, M., Gorelik, L., Lowdell, M. W. & Rowinsky, E., Aug 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 8, p. 1581-1589 9 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Natural Killer Cells
Tissue Donors
Recurrence
Immunotherapy

ARID5B regulates metabolic programming in human adaptive NK cells

Cichocki, F. M., Wu, C. Y., Zhang, B., Felices, M., Tesi, B., Tuininga, K., Dougherty, P., Taras, E., Hinderlie, P., Blazar, B. R., Bryceson, Y. T. & Miller, J. S., Jan 1 2018, In : Journal of Experimental Medicine. 215, 9, p. 2379-2395 17 p.

Research output: Contribution to journalArticle

1 Citations

Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples

Rashidi, A., Shanley, R. M., Yohe, S. L., Thyagarajan, B., Curtsinger, J., Anasetti, C., Waller, E. K., Miller, J. S., Blazar, B. R. & Weisdorf, D. J., Aug 1 2018, In : Bone Marrow Transplantation. 53, 8, p. 1069-1071 3 p.

Research output: Contribution to journalLetter

trans-crotonin

Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution

Williams, S. M., Sumstad, D., Kadidlo, D., Curtsinger, J., Luo, X., Miller, J. S. & Mckenna, D. H., Jun 1 2018, In : Transfusion. 58, 6, p. 1458-1467 10 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Immunotherapy
Interleukin-15
Interleukin-2
B-Lymphocytes
4 Citations

Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML

Bjorklund, A. T., Carlsten, M., Sohlberg, E., Liu, L. L., Clancy, T., Karimi, M., Cooley, S. A., Miller, J. S., Klimkowska, M., Schaffer, M., Watz, E., Wikstrom, K., Blomberg, P., Wahlin, B. E., Palma, M., Hansson, L., Ljungman, P., Hellstrom-Lindberg, E., Ljunggren, H. G. & Malmberg, K. J., Apr 15 2018, In : Clinical Cancer Research. 24, 8, p. 1834-1844 11 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Risk Reduction Behavior
Cell- and Tissue-Based Therapy
Natural Killer Cells
Clone Cells
1 Citations

Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy

de Witte, M. A., Sarhan, D., Davis, Z., Felices, M., Vallera, D. A., Hinderlie, P., Curtsinger, J., Cooley, S. A., Wagner, J. E., Kuball, J. & Miller, J. S., Jun 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 6, p. 1152-1162 11 p.

Research output: Contribution to journalArticle

Natural Killer T-Cells
Hematopoietic Stem Cell Transplantation
Immunotherapy
T-Lymphocytes
Transplants
1 Citations

Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models

Liu, B., Jones, M., Kong, L., Noel, T., Jeng, E. K., Shi, S., England, C. G., Alter, S., Miller, J. S., Cai, W., Rhode, P. R. & Wong, H. C., Jul 1 2018, In : Cytokine. 107, p. 105-112 8 p.

Research output: Contribution to journalArticle

Interleukin-15
Bioactivity
Tumors
Subcutaneous Injections
Intravenous Injections
7 Citations

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Romee, R., Cooley, S. A., Berrien-Elliott, M. M., Westervelt, P., Verneris, M. R., Wagner, J. E., Weisdorf, D. J., Blazar, B. R., Ustun, C., De For, T. E., Vivek, S., Peck, L., DiPersio, J. F., Cashen, A. F., Kyllo, R., Musiek, A., Schaffer, A., Anadkat, M. J., Rosman, I., Miller, D. D. & 6 othersEgan, J. O., Jeng, E. K., Rock, A., Wong, H. C., Fehniger, T. A. & Miller, J. S., Jun 7 2018, In : Blood. 131, 23, p. 2515-2527 13 p.

Research output: Contribution to journalArticle

Interleukin-15
T-cells
Transplantation
Recurrence
Cell Transplantation
2 Citations
Natural Killer Cells
Non-Hodgkin's Lymphoma
Tissue Donors
Interleukin-15
Immunosuppressive Agents
3 Citations

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice

Pennell, C. A., Barnum, J. L., McDonald-Hyman, C. S., Panoskaltsis-Mortari, A., Riddle, M. J., Xiong, Z., Loschi, M., Thangavelu, G., Campbell, H. M., Storlie, M. D., Refaeli, Y., Furlan, S. N., Jensen, M. C., Kean, L. S., Miller, J. S., Tolar, J., Osborn, M. J. & Blazar, B. R., Jun 6 2018, In : Molecular Therapy. 26, 6, p. 1423-1434 12 p.

Research output: Contribution to journalArticle

Transgenic Mice
B-Lymphocytes
T-Lymphocytes
T-Cell Antigen Receptor
Antigen Receptors
1 Citations

Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells

Burrack, K. S., Huggins, M. A., Taras, E., Dougherty, P., Henzler, C. M., Yang, R., Alter, S., Jeng, E. K., Wong, H. C., Felices, M., Cichocki, F., Miller, J. S., Hart, G. T., Johnson, A. J., Jameson, S. C. & Hamilton, S. E., Apr 17 2018, In : Immunity. 48, 4, p. 760-772.e4

Research output: Contribution to journalArticle

Cerebral Malaria
Interleukin-15
Natural Killer Cells
Interleukin-10
Blood-Brain Barrier
1 Citations

KIR Donor Selection: Feasibility in Identifying better Donors

the participating center writing committee, Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Donor Selection
Immunoglobulins
Tissue Donors
Transplants
Acute Myeloid Leukemia

Natural killer cell-based immunotherapy in gynecologic malignancy: A review

Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M. & Geller, M. A., Jan 5 2018, In : Frontiers in Immunology. 8, JAN, 1825.

Research output: Contribution to journalReview article

Natural Killer Cells
Immunotherapy
Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

Hoogstad-Van Evert, J. S., Maas, R. J., Van Der Meer, J., Cany, J., Van Der Steen, S., Jansen, J. H., Miller, J. S., Bekkers, R., Hobo, W., Massuger, L. & Dolstra, H., Oct 1 2018, In : Oncotarget. 9, 78, p. 34810-34820 11 p.

Research output: Contribution to journalArticle

Interleukin-15
Natural Killer Cells
Ovarian Neoplasms
Carcinoma
Ascites

Prevention and treatment of relapse after stem cell transplantation by cellular therapies

Falkenburg, F., Ruggiero, E., Bonini, C., Porter, D., Miller, J. S., Malard, F., Mohty, M., Kröger, N. & Kolb, H. J., May 24 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-9 9 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Secondary Prevention
T-Lymphocytes
Homologous Transplantation
Therapeutics
1 Citations

Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016

Al Malki, M. M., Jones, R., Ma, Q., Lee, D., Reisner, Y., Miller, J. S., Lang, P., Hongeng, S., Hari, P., Strober, S., Yu, J., Maziarz, R., Mavilio, D., Roy, D. C., Bonini, C., Champlin, R. E., Fuchs, E. J. & Ciurea, S. O., May 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 5, p. 895-908 14 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Tissue Donors
T-Lymphocytes
Transplantation
Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
Allografts
Graft vs Host Disease
Cell Transplantation
Transplants
1 Citations

Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation

Cooley, S. A., Parham, P. & Miller, J. S., Mar 8 2018, In : Blood. 131, 10, p. 1053-1062 10 p.

Research output: Contribution to journalReview article

KIR Receptors
Hematopoietic Stem Cell Transplantation
Stem cells
Natural Killer Cells
Recurrence
2017

Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state

Rashidi, A., Ali, A. M., Vij, K. R., Shanley, R., Romee, R., Cooley, S. A., Westervelt, P., DiPersio, J. F., Miller, J. S., Weisdorf, D. J. & Ustun, C., Sep 1 2017, In : American Journal of Hematology. 92, 9, p. E549-E552

Research output: Contribution to journalLetter

Cell Transplantation
Leukemia
2 Citations
7 Citations

Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant

Tkachev, V., Furlan, S. N., Watkins, B., Hunt, D. J., Betty Zheng, H., Panoskaltsis-Mortari, A., Betz, K., Brown, M., Schell, J. B., Zeleski, K., Yu, A., Kirby, I., Cooley, S., Miller, J. S., Blazar, B. R., Casson, D., Bland-Ward, P. & Kean, L. S., Sep 20 2017, In : Science Translational Medicine. 9, 408, eaan3085.

Research output: Contribution to journalArticle

Sirolimus
Eragrostis
Graft vs Host Disease
T-Lymphocytes
Transplants
Hematologic Neoplasms
Blood Donors
Fetal Blood
Dendritic Cells
Siblings
6 Citations
Antibody-Dependent Cell Cytotoxicity
Natural Killer Cells
Interleukin-15
Neoplastic Stem Cells
Interferon-gamma
10 Citations

GSK3 inhibition drives maturation of NK cells and enhances their antitumor activity

Cichocki, F. M., Valamehr, B., Bjordahl, R., Zhang, B., Rezner, B., Rogers, P., Gaidarova, S., Moreno, S., Tuininga, K., Dougherty, P., McCullar, V., Howard, P., Sarhan, D., Taras, E., Schlums, H., Abbot, S., Shoemaker, D., Bryceson, Y. T., Blazar, B. R., Wolchko, S. & 2 othersCooley, S. A. & Miller, J. S., Oct 15 2017, In : Cancer Research. 77, 20, p. 5664-5675 12 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Neoplasms
Phosphotransferases
Immunologic Monitoring
Interleukin-15
4 Citations

HLA-Bw4-I-80 isoform differentially influences clinical outcome as compared to HLA-Bw4-T-80 and HLA-A-Bw4 isoforms in rituximab or dinutuximab-based cancer immunotherapy

Erbe, A. K., Wang, W., Reville, P. K., Carmichael, L., Kim, K. M., Mendonca, E. A., Song, Y., Hank, J. A., London, W. B., Naranjo, A., Hong, F., Hogarty, M. D., Maris, J. M., Park, J. R., Ozkaynak, M. F., Miller, J. S., Gilman, A. L., Kahl, B., Yu, A. L. & Sondel, P. M., Jun 12 2017, In : Frontiers in Immunology. 8, JUN, 675.

Research output: Contribution to journalArticle

HLA-A Antigens
Immunotherapy
Epitopes
Protein Isoforms
KIR Receptors
17 Citations

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer

Felices, M., Chu, S., Kodal, B., Bendzick, L., Ryan, C., Lenvik, A. J., Boylan, K. L. M., Wong, H. C., Skubitz, A. P. N., Miller, J. S. & Geller, M. A., Jun 1 2017, In : Gynecologic Oncology. 145, 3, p. 453-461 9 p.

Research output: Contribution to journalArticle

Interleukin-15
Natural Killer Cells
Ovarian Neoplasms
Ascites
ALT-803
2 Citations

In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines

Hippen, K. L., O'Connor, R. S., Lemire, A. M., Saha, A., Hanse, E. A., Tennis, N. C., Merkel, S. C., Kelekar, A., Riley, J. L., Levine, B. L., June, C. H., Turka, L. A., Kean, L. S., MacMillan, M. L., Miller, J. S., Wagner, J. E., Munn, D. H. & Blazar, B. R., Dec 1 2017, In : American Journal of Transplantation. 17, 12, p. 3098-3113 16 p.

Research output: Contribution to journalArticle

Kynurenine
Regulatory T-Lymphocytes
Tryptophan
Interleukin-2
Graft vs Host Disease
3 Citations

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen–Matched Grafts

Brunstein, C. G., Cutler, C. S., DeFor, T. E., Kim, H., Bejanyan, N., Garfall, A., Verneris, M. R., Chen, Y. B., Warlick, E. D., Spitzer, T., Miller, J. S., Antin, J. H., Weisdorf, D. J., Soiffer, R., Wagner, J. E. & Ballen, K. K., Jan 1 2017, In : Biology of Blood and Marrow Transplantation. 23, 1, p. 126-133 8 p.

Research output: Contribution to journalArticle

HLA-C Antigens
HLA Antigens
Fetal Blood
Transplantation
Transplants

Natural Killer Cell-Based Therapies

Cooley, S. A., Verneris, M. R. & Miller, J. S., Aug 15 2017, Hematology: Basic Principles and Practice. Elsevier Inc., p. 1575-1582 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Citations
Natural Killer Cells
Immunotherapy
Neoplasms
Neoplasm Antigens
Tumor Escape
8 Citations

Optimization of cGMP purification and expansion of umbilical cord blood–derived T-regulatory cells in support of first-in-human clinical trials

McKenna, D. H., Sumstad, D., Kadidlo, D. M., Batdorf, B., Lord, C. J., Merkel, S. C., Koellner, C. M., Curtsinger, J. M., June, C. H., Riley, J. L., Levine, B. L., Miller, J. S., Brunstein, C. G., Wagner, J. E., Blazar, B. R. & Hippen, K. L., Feb 1 2017, In : Cytotherapy. 19, 2, p. 250-262 13 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Fetal Blood
Clinical Trials
Graft vs Host Disease
Antigen-Presenting Cells
4 Citations

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes

Hoff, G. A., Fischer, J. C., Hsu, K., Cooley, S., Miller, J. S., Wang, T., Haagenson, M., Spellman, S., Lee, S. J., Uhrberg, M., Venstrom, J. M. & Verneris, M. R., Jan 1 2017, In : Biology of Blood and Marrow Transplantation. 23, 1, p. 153-160 8 p.

Research output: Contribution to journalArticle

HLA-C Antigens
Cell Transplantation
MicroRNAs
Haplotypes
Binding Sites
Adoptive Transfer
Natural Killer Cells
T-Lymphocytes
Tissue Donors
Remission Induction
2016
23 Citations

Adaptive NK cells with low TIGIT expression are inherently resistant to myeloid-derived suppressor cells

Sarhan, D., Cichocki, F., Zhang, B., Yingst, A., Spellman, S. R., Cooley, S., Verneris, M. R., Blazar, B. R. & Miller, J. S., Oct 1 2016, In : Cancer Research. 76, 19, p. 5696-5706 11 p.

Research output: Contribution to journalArticle

Natural Killer Cells
T-Lymphocytes
Reactive Oxygen Species
Costimulatory and Inhibitory T-Cell Receptors
Neoplasms
28 Citations

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control

Koehl, U., Kalberer, C., Spanholtz, J., Lee, D. A., Miller, J. S., Cooley, S., Lowdell, M., Uharek, L., Klingemann, H., Curti, A., Leung, W. & Alici, E., Apr 2 2016, In : OncoImmunology. 5, 4

Research output: Contribution to journalReview article

Donor Selection
Natural Killer Cells
Quality Control
Antigen Receptors
Cell- and Tissue-Based Therapy
62 Citations

CD56 dim CD57+ NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT

Cichocki, F. M., Cooley, S. A., Davis, Z., De For, T. E., Schlums, H., Zhang, B., Brunstein, C. G., Blazar, B. R., Wagner, J. E., Diamond, D. J., Verneris, M. R., Bryceson, Y. T., Weisdorf, D. J. & Miller, J. S., Feb 1 2016, In : Leukemia. 30, 2, p. 456-463 8 p.

Research output: Contribution to journalArticle

Cytomegalovirus
Natural Killer Cells
Leukemia
Transplants
Recurrence
16 Citations

Diversification and functional specialization of human NK cell subsets

Cichocki, F. M., Schlums, H., Theorell, J., Tesi, B., Miller, J. S., Ljunggren, H. G. & Bryceson, Y. T., Feb 1 2016, In : Current Topics in Microbiology and Immunology. 395, p. 63-93 31 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Immunologic Monitoring
Immunity
Cytokines
Disease Susceptibility
8 Citations

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation

Bachanova, V., Weisdorf, D. J., Wang, T., Marsh, S. G. E., Trachtenberg, E., Haagenson, M. D., Spellman, S. R., Ladner, M., Guethlein, L. A., Parham, P., Miller, J. S. & Cooley, S. A., Sep 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 9, p. 1602-1607 6 p.

Research output: Contribution to journalArticle

KIR Receptors
Unrelated Donors
Non-Hodgkin's Lymphoma
Disease-Free Survival
Transplantation
13 Citations

Enhanced ADCC and NK cell activation of an anticarcinoma bispecific antibody by genetic insertion of a modified IL-15 cross-linker

Schmohl, J. U., Felices, M., Taras, E., Miller, J. S. & Vallera, D. A., Aug 1 2016, In : Molecular Therapy. 24, 7, p. 1312-1322 11 p.

Research output: Contribution to journalArticle

Bispecific Antibodies
Antibody-Dependent Cell Cytotoxicity
Interleukin-15
Natural Killer Cells
Cytokines
46 Citations

Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases

Osborn, M. J., Webber, B. R., Knipping, F., Lonetree, C. L., Tennis, N., DeFeo, A. P., McElroy, A. N., Starker, C. G., Lee, C., Merkel, S., Lund, T. C., Kelly-Spratt, K. S., Jensen, M. C., Voytas, D. F., Von Kalle, C., Schmidt, M., Gabriel, R., Hippen, K. L., Miller, J. S., Scharenberg, A. M. & 2 othersTolar, J. & Blazar, B. R., Mar 1 2016, In : Molecular Therapy. 24, 3, p. 570-581 12 p.

Research output: Contribution to journalArticle

Clustered Regularly Interspaced Short Palindromic Repeats
T-Lymphocytes
T-Cell Antigen Receptor
Adoptive Immunotherapy
Neoplasm Antigens
10 Citations

Generation of BiKEs and TriKEs to improve NK cell-mediated targeting of tumor cells

Felices, M., Lenvik, T. R., Davis, Z. B., Miller, J. S. & Vallera, D. A., Jan 1 2016, Methods in Molecular Biology. Humana Press Inc., p. 333-346 14 p. (Methods in Molecular Biology; vol. 1441).

Research output: Chapter in Book/Report/Conference proceedingChapter

Natural Killer Cells
Antibodies
Neoplasms
Immunotherapy
Natural Killer Cell Receptors
16 Citations

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells

Schmohl, J. U., Gleason, M. K., Dougherty, P. R., Miller, J. S. & Vallera, D. A., Jun 1 2016, In : Targeted Oncology. 11, 3, p. 353-361 9 p.

Research output: Contribution to journalArticle

Single-Chain Antibodies
Natural Killer Cells
Colorectal Neoplasms
Neoplastic Stem Cells
Pharmaceutical Preparations
49 Citations
Interleukin-15
Natural Killer Cells
Antigens
Cell Degranulation
Survival